Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection.
about
Therapy of Helicobacter pylori: present medley and future prospectiveRescue Therapy with a Proton Pump Inhibitor Plus Amoxicillin and Rifabutin for Helicobacter pylori Infection: A Systematic Review and Meta-AnalysisEfficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection'Rescue' therapies for the management of Helicobacter pylori infection.Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection.Second-line rescue therapy of helicobacter pylori infection.Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential.Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.American College of Gastroenterology guideline on the management of Helicobacter pylori infection.Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures.Rifabutin-based high-dose proton-pump inhibitor and amoxicillin triple regimen as the rescue treatment for Helicobacter pyloriEfficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial.Is There Any Advantage of Treating Partners in Helicobacter pylori Eradication?Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.Eradication of Helicobacter pylori: recent advances in treatment.Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.Helicobacter pylori infection: treatment options.Eradication of Helicobacter pylori: are rifaximin-based regimens effective?Effective regimens for the treatment of Helicobacter pylori infection.Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic.Economic evaluation of test-and-treat and empirical treatment strategies in the eradication of Helicobacter pylori infection; A Markov model in an Iranian adult population.Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice."Rescue" regimens after Helicobacter pylori treatment failure.Helicobacter pylori: testing and treatment.Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations.Emerging therapies for the treatment of Helicobacter pylori infections.Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection.Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures.Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies.Eradication of H. pylori Infection: the Challenge is on if Standard Therapy FailsIn Silico Profiling of the Potentiality of Curcumin and Conventional Drugs for CagA Oncoprotein Inactivation.Should quinolones come first in Helicobacter pylori therapy?Reply to letter to the editor: "The dosage of rifabutin in H. pylori eradication regimen should be appropriately determined in each area of the world"First-line therapy in Helicobacter pylori eradication therapy: experience of a surgical clinic.Rescue Therapy for Helicobacter pylori Infection 2012.Third-line rescue therapy for Helicobacter pylori infection.Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese.
P2860
Q26823120-B3DEF9F3-CD2C-4ABF-9488-54E8F1F3156FQ28085359-B1724134-6B4B-4D3C-A245-F546740A65F6Q33291670-60A84802-C47A-45CD-A300-0F7A78D71C67Q33371187-9040C180-D7DE-4D13-839A-90928520E511Q33916743-9CD260DF-A4E7-4FC1-90F5-09230EA4BE8EQ34409114-54821352-182B-4591-B632-A0F079F1DF2FQ34557101-DEFA7D21-8C8E-4BE7-8855-9A76AF29E64BQ34570815-AEEC0831-CEB4-472B-8E96-B90F70FEA5BDQ34645482-97EE7831-8C84-4354-83D8-35FD1DCC95A1Q34774061-ECEB66D2-5E5F-4AD5-AAB2-0F4C041E2C46Q34823645-6649492D-07C9-4BF2-8E43-FADE90302D5DQ35009862-3EE2328F-8C91-47BC-9BAC-19EF08A539B2Q35227069-C3A280DD-26C5-4BB5-9AE3-A2D19A5DA353Q35594239-958D67E2-4AF4-4625-87E1-A2C417F091EBQ36191284-B6DD283B-7606-438B-BC79-E50A59EF72DFQ36322095-AE758FFA-28C9-4DAA-8C63-B5E6580770DBQ36360546-9F492CF4-2E46-4A36-B7EA-2240BFE13072Q36404967-B18EE0EE-7B92-47A4-9EE2-ECCFD7AF3488Q36404971-3C8579B1-06DB-4F18-88AD-9A9A200E9BE1Q36568724-924D8E19-8CAD-4511-A59F-9C06CAFBC46EQ36723844-DAE2CF46-1E7A-4EBA-AD53-B6B81FC60350Q36983299-1CDF9CC2-3EA2-4F58-A545-884F8029D9AFQ37144924-11C43ACC-2954-44FF-86BF-C3B1D6CFCE40Q37273653-E3B691CA-1B4B-4B87-AA45-208724A9E504Q37346038-D4345F22-D518-49AB-87BC-43F05717CD6CQ37963008-56153558-440C-4269-8772-23BCF135E756Q38052634-0CA461D4-E820-479E-B805-D55630CEFA38Q38424698-E6C7FE84-A0D9-45D2-9EAC-1DF968CF4CB1Q38882190-6DA36D9F-5103-4E6F-B6AA-0F52EB695B68Q40294669-89739960-BDC6-4EAE-9DD9-FDDF5036D847Q40819420-2FD338E6-52D4-4DF9-82AA-2D81943D1CA2Q41172569-34301545-EF2B-4435-9469-4EAA84A6E0B1Q41211362-96203370-F557-452B-BBE6-03A6E72838D7Q41807465-67DA32A1-6397-47BE-879D-14EDB27CA126Q41941999-A4046E21-9435-45BC-848F-88E60D8A089FQ41993795-71C83BBB-7317-4458-918D-89099F5D5240Q42129420-142396F8-1AEF-4399-B33A-E741ADF20967Q42726333-D7BC8BC2-CBAD-4AF6-A4ED-4E12C3C5F3DCQ43531758-66DF509E-EDB1-4300-A933-C693AA8644B5Q43663481-63FA4393-6D87-47E6-A4F2-B8644C039F9D
P2860
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Randomized controlled study of ...... Helicobacter pylori infection.
@en
Randomized controlled study of ...... Helicobacter pylori infection.
@nl
type
label
Randomized controlled study of ...... Helicobacter pylori infection.
@en
Randomized controlled study of ...... Helicobacter pylori infection.
@nl
prefLabel
Randomized controlled study of ...... Helicobacter pylori infection.
@en
Randomized controlled study of ...... Helicobacter pylori infection.
@nl
P2093
P2860
P1476
Randomized controlled study of ...... Helicobacter pylori infection.
@en
P2093
B C Y Wong
F M Y Fung
P2860
P304
P356
10.1046/J.1365-2036.2003.01459.X
P407
P577
2003-02-01T00:00:00Z